Interact to see
Advertisement
Advertisement
ADNRX vs PAMCX
ADNRX vs PAMCX Comparison
Open Charts ADNRX vs PAMCX
American Beacon ARK Transfmt Innov R6
Price$23.59
Change-$0.18 (-0.76%)
VolumeN/A
Net Assets232.03M
T. Rowe Price Mid-Cap Growth Adv
Price$96.08
Change+$0.27 (+0.28%)
VolumeN/A
Net Assets26.14B
ADNRX vs PAMCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
ADNRX vs. PAMCX commentary
Oct 19, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Hold and PAMCX is a Hold.
FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 26.1B vs. ADNRX (232M). ADNRX (0.00) and PAMCX (0.00) have matching dividends . ADNRX was incepted earlier than PAMCX: ADNRX (5 years) vs PAMCX (26 years). ADNRX (1.13) is less costly to investors than PAMCX (1.01). ADNRX is a more actively managed with annual turnover of: 46.00 vs. PAMCX (22.60). ADNRX has a lower initial minimum investment than PAMCX: ADNRX (0) vs PAMCX (2500). ADNRX annual gain was more profitable for investors over the last year : 82.30 vs. PAMCX (-8.20).
| ADNRX | PAMCX | ADNRX / PAMCX | |
| Total Expense Ratio | 1.00 | 1.01 | 99% |
| Annual Report Gross Expense Ratio | 1.13 | 1.01 | 112% |
| Fund Existence | 5 years | 26 years | - |
| Gain YTD | 51.315 | 2.256 | 2,274% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 232M | 26.1B | 1% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 82.30 | -8.20 | -1,004% |
| Returns for 3 years | 117.22 | 17.07 | 687% |
| Returns for 5 years | N/A | -6.56 | - |
| Returns for 10 years | N/A | 23.83 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers